4178F Antid glbln rcvd with in 26wks
Also known as: immunosuppressive therapy measure, antidiuretic globulin measure, aplastic anemia treatment
Performance measure code indicating that antidiuretic globulin or immunosuppressive therapy was received within 26 weeks.
In Plain Language
aplastic anemia treatment medication; immune system suppression therapy; bone marrow failure treatment
Clinical Context
Quality measure for aplastic anemia care tracking receipt of appropriate immunosuppressive therapy including antithymocyte globulin.
RVU Information
CPT 4178F does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Documentation should include the clinical indication, service details, and any applicable performance metrics. Coverage may vary by payer — verify acceptance before billing.
Specialties
Frequently Asked Questions
What is CPT code 4178F?
CPT 4178F (Antid glbln rcvd with in 26wks) is a Other code. Performance measure code indicating that antidiuretic globulin or immunosuppressive therapy was received within 26 weeks.
Who uses CPT code 4178F?
CPT 4178F is used by Hematology, Oncology, Internal Medicine. Quality measure for aplastic anemia care tracking receipt of appropriate immunosuppressive therapy including antithymocyte globulin.
When is CPT 4178F used?
Quality measure for aplastic anemia care tracking receipt of appropriate immunosuppressive therapy including antithymocyte globulin.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.